Press Release

Shanghai Fourier Intelligence Turns New Leaf in Global Research on Rehabilitation with New Joint Lab

After building a joint laboratory with the University of Melbourne in July 2018, the 4-year-old Shanghai startup has joined hands with the prestigious Shirley Ryan AbilityLab in Chicago, the US. The three sides inked an MoU to create a new joint lab that will apply the latest research in physical medicine and rehabilitation to help people with disabilities or other forms of mobility impairment.

22/Jul/2019



Shanghai, July 3, 2019 – Shanghai Fourier Intelligence, a leader in cutting-edge rehabilitation robotics, and the University of Melbourne have ushered in a new chapter in their exploration of rehab research and solutions by partnering with Shirley Ryan AbilityLab in the United States.

(From left) Dr José Pons, Scientific Chair of Legs + Walking Lab at Shirley Ryan AbilityLab, and Dr Richard Lieber, SVP & Chief Scientific Officer at Shirley Ryan AbilityLab, pose for a photo with Zen Koh, Deputy CEO & CSO of Shanghai Fourier Intelligence Co. Ltd, and Dr Denny Oetomo, Associate Professor & Deputy Head (Academic) of the Department of Mechanical Engineering at the University of Melbourne after signing a memorandum of understanding (MoU) on July 2 to inaugurate their new joint research laboratory. —— Photos courtesy of Shirley Ryan AbilityLab.

The University of Melbourne – Fourier Intelligence Lab (hereafter referred to as UOM-FI), which was established in July 2018, signed a memorandum of understanding (MoU) on July 2 with the premier Chicago-based rehabilitation hospital and announced the formation of a joint laboratory to promote research in areas including, among others, neuroscience, physical therapy, biomechanics, robotics, machine learning and major diseases of the central nervous system such as stroke, spinal cord injury and Parkinson's disease.

"Part of our goal in founding the lab with Shirley Ryan AbilityLab is to employ the most up-to-date rehab technology for commercial applications, so as to help patients globally," said Alex Gu, founder and CEO of Fourier Intelligence, a startup company founded four years ago.

Fourier is one of the first Chinese rehabilitation robotics companies to team up with a top-ranked research hospital like Shirley Ryan AbilityLab, which brings clinicians, scientists, innovators and technologists together to produce science-driven breakthroughs in human ability.

The inception of the new laboratory also signals the company's ambitions to become a pioneer in driving translational rehabilitation research to aid the recovery of those with mobility impairments. This process began early this year with the release of EXOPS, an open-source, Android-like platform with functionalities for researchers to build on to develop the next-generation wearable exoskeleton.

The purpose of the collaboration between UOM-FI and Shirley Ryan AbilityLab is to ultimately "translate innovative, cost-effective treatments at a clinical and company level," said Zen Koh, Chief Strategy Officer of Fourier.

The façade of Shirley Ryan AbilityLab. Based in Chicago, Il, Shirley Ryan AbilityLab is the global leader in physical medicine and rehabilitation for adults and children with the most severe, complex conditions — from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment.

The joint laboratory will be headed by Dr. José L. Pons, Scientific Chair of the Legs + Walking Lab at Shirley Ryan AbilityLab, and Dr. Denny Oetomo, Associate Professor at the Department of Mechanical Engineering of UOM-Fl. Shirley Ryan AbilityLab will lead on research methodologies and design. Meanwhile, UoM-FI will validate and support the initiatives, with Fourier providing the EXOPS system to be used for the research purpose. Both organizations will fund researchers to carry out projects in the new laboratory.

"We believe Fourier's EXOPS open platform system will lead to future innovation and advancement of rehabilitation robotics technologies," said Pons after signing the MoU. "We will collaborate to promote this effort jointly."

As the only Chinese company to have landed accreditations or licenses from food and drug administrations in the United States, European Union, Australia and China, Fourier's launch of the partnership with Shirley Ryan AbilityLab is also a hallmark of the company making inroads in the North American market.

"Medicine knows no borders. Fourier will offer top quality products tailored to American users as well as in keeping with the standards adopted by the American rehab care and service system," said Alex Gu, adding that the newly forged partnership will strengthen Fourier's branding and presence in North America.

"With our cooperation with Shirley Ryan AbilityLab, whose leading care and research is often celebrated as the industry benchmark, Fourier will invite more clinicians and researchers in the rehab industry to initiate 'translational' research," Koh noted.

About Fourier Intelligence
Fourier Intelligence is an innovative global technology company focusing on developing, manufacturing and marketing of rehabilitation robotics and exoskeleton. The company is committed to making life easier for overworked therapists by cutting their workload since much of their treatment is person to person. Fourier’s ultimate goal is to enhance the efficiency of therapy for stroke victims and other patients and help to fill the shortfall of qualified therapists in China and beyond.

About Shirley Ryan AbilityLab
The Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago (RIC), is the global leader in physical medicine and rehabilitation for adults and children with the most severe, complex conditions — from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment. The organization expands and accelerates leadership in the field that began at RIC in 1953. The quality of its care and research has led to the designation of "No. 1 Rehabilitation Hospital in America" by U.S. News & World Report every year since 1991. Upon opening in March 2017, the $550 million, 1.2-million-square-foot Shirley Ryan AbilityLab became the first-ever "translational" research hospital in which clinicians, scientists, innovators and technologists work together in the same space, surrounding patients, discovering new approaches and applying (or "translating") research real time. This unique model enables patients to have 24/7 access to the brightest minds, the latest research and the best opportunity for recovery. The Shirley Ryan AbilityLab is a 501 (c)(3) nonprofit organization. For more information, go to www.sralab.org. 

For investor and media inquiries, please contact:
Mr Zen Koh (Deputy CEO / Chief Strategy Officer)
Fourier Intelligence
Phone: +65-9338-2328
Email: zen.koh@fftai.com

Megan Washburn (Executive Director, Communications)
Shirley Ryan AbilityLab
Phone: +1.312.238.6016
Email: mwashburn@sralab.org

News

Invention

Applications

cancel
0 results found

Filtration Standard

News

Company

Products